| # | Drug | Count |
|---|---|---|
| 0 | EFAVIRENZ | 6 |
| 1 | LAMIVUDINE | 6 |
| 2 | LAMIVUDINE ORAL | 5 |
| 3 | ISONIAZID | 4 |
| 4 | PYRAZINAMIDE | 4 |
| 5 | RIFAMPICIN | 4 |
| 6 | ZIDOVUDINE | 3 |
| 7 | ABACAVIR | 2 |
| 8 | ABACAVIR SULFATE | 2 |
| 9 | CIDOFOVIR ANHYDROUS | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIFLORASONE DIACETATE | 1 | 0.0052 |
| 1 | CIDOFOVIR ANHYDROUS | 2 | 0.0014 |
| 2 | HALOBETASOL PROPIONATE | 1 | 0.0007 |
| 3 | EFAVIRENZ | 6 | 0.0005 |
| 4 | PYRAZINAMIDE | 4 | 0.0004 |
| 5 | RIFAMPICIN | 4 | 0.0004 |
| 6 | PYRIDOXINE HYDROCHLORIDE | 1 | 0.0004 |
| 7 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 8 | ZIDOVUDINE | 3 | 0.0003 |
| 9 | PHENAZOPYRIDINE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0002 |
| 1 | Antimycobacterial [EPC] | 4 | 0.0002 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 5 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 6 | Azole Antifungal [EPC] | 3 | 0.0000 |
| 7 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 8 | Estrogen [EPC] | 1 | 0.0000 |
| 9 | Osmotic Laxative [EPC] | 1 | 0.0000 |